A collaborative randomised phase III trial: The timing of intervention with androgen deprivation in prostate cancer patients with a rising PSA.
Primary Sponsor
Trans-Tasman Radiation Oncology Group (TROG)
Related Post
12 November, 2025
Veterans golf club swings behind TROG Cancer Research
LATEST NEWS: 12 November 2025 More than 100 golfers
6 November, 2025
SUPREMO trial findings signal change in breast cancer treatment
LATEST NEWS: 6 November 2025 Radiotherapy can be safely